NASDAQ:AEZS
$2.75
(
-1.11%
)
Friday, 2nd Jun 2023
AEterna Zentaris Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.50 | $3.30 | Friday, 2nd Jun 2023 AEZS stock ended at $2.75. This is 1.11% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 10.76% from a day low at $2.51 to a day high of $2.78. |
| 90 days | $2.32 | $3.41 | |
| 52 weeks | $2.32 | $8.63 |
Historical AEterna Zentaris Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $2.75 | $2.78 | $2.51 | $2.75 | 57 259 |
| 2023-06-01 | $2.77 | $2.85 | $2.76 | $2.78 | 3 526 |
| 2023-05-31 | $2.82 | $2.82 | $2.75 | $2.78 | 9 154 |
| 2023-05-30 | $2.80 | $2.83 | $2.76 | $2.78 | 4 217 |
| 2023-05-26 | $2.86 | $2.89 | $2.78 | $2.81 | 4 982 |
| 2023-05-25 | $3.03 | $3.03 | $2.80 | $2.89 | 7 573 |
| 2023-05-24 | $3.06 | $3.06 | $3.02 | $3.03 | 2 643 |
| 2023-05-23 | $3.01 | $3.15 | $3.01 | $3.04 | 21 861 |
| 2023-05-22 | $2.92 | $3.01 | $2.84 | $2.99 | 5 059 |
| 2023-05-19 | $2.82 | $2.99 | $2.80 | $2.96 | 9 243 |
| 2023-05-18 | $2.78 | $2.96 | $2.71 | $2.85 | 6 803 |
| 2023-05-17 | $2.70 | $2.83 | $2.50 | $2.78 | 11 499 |
| 2023-05-16 | $2.91 | $2.99 | $2.70 | $2.76 | 16 255 |
| 2023-05-15 | $2.90 | $3.00 | $2.90 | $2.98 | 3 929 |
| 2023-05-12 | $3.05 | $3.07 | $2.92 | $2.92 | 10 650 |
| 2023-05-11 | $2.99 | $3.03 | $2.98 | $3.00 | 5 070 |
| 2023-05-10 | $3.02 | $3.18 | $3.02 | $3.06 | 4 830 |
| 2023-05-09 | $3.03 | $3.12 | $2.89 | $3.10 | 3 885 |
| 2023-05-08 | $3.29 | $3.30 | $3.12 | $3.12 | 12 630 |
| 2023-05-05 | $3.07 | $3.20 | $2.99 | $3.13 | 13 649 |
| 2023-05-04 | $2.85 | $3.05 | $2.82 | $2.99 | 27 727 |
| 2023-05-03 | $2.85 | $2.87 | $2.84 | $2.86 | 4 471 |
| 2023-05-02 | $3.13 | $3.13 | $2.71 | $2.83 | 24 357 |
| 2023-05-01 | $3.13 | $3.23 | $3.10 | $3.10 | 10 457 |
| 2023-04-28 | $3.38 | $3.30 | $3.15 | $3.15 | 18 968 |
| 2023-04-27 | $3.22 | $3.25 | $3.20 | $3.21 | 11 333 |
| 2023-04-26 | $3.20 | $3.26 | $3.20 | $3.22 | 18 710 |
| 2023-04-25 | $3.20 | $3.30 | $3.20 | $3.23 | 18 566 |
| 2023-04-24 | $3.12 | $3.22 | $3.01 | $3.20 | 21 816 |
| 2023-04-21 | $3.01 | $3.15 | $2.97 | $3.09 | 15 272 |
| 2023-04-20 | $3.15 | $3.15 | $3.01 | $3.01 | 10 964 |
| 2023-04-19 | $3.08 | $3.15 | $3.06 | $3.15 | 7 648 |
| 2023-04-18 | $2.71 | $3.14 | $2.70 | $3.10 | 64 651 |
| 2023-04-17 | $2.59 | $2.78 | $2.59 | $2.75 | 29 310 |
| 2023-04-14 | $2.70 | $2.70 | $2.59 | $2.62 | 4 834 |
| 2023-04-13 | $2.65 | $2.65 | $2.59 | $2.64 | 2 324 |
| 2023-04-12 | $2.70 | $2.70 | $2.60 | $2.61 | 27 408 |
| 2023-04-11 | $2.68 | $2.68 | $2.56 | $2.64 | 13 199 |
| 2023-04-10 | $2.42 | $2.67 | $2.42 | $2.55 | 34 737 |
| 2023-04-06 | $2.50 | $2.57 | $2.32 | $2.45 | 17 251 |
| 2023-04-05 | $2.48 | $2.62 | $2.42 | $2.45 | 19 972 |
| 2023-04-04 | $2.50 | $2.64 | $2.39 | $2.57 | 31 802 |
| 2023-04-03 | $2.63 | $2.65 | $2.48 | $2.50 | 21 120 |
| 2023-03-31 | $2.69 | $2.71 | $2.49 | $2.62 | 25 778 |
| 2023-03-30 | $2.73 | $2.75 | $2.61 | $2.68 | 7 205 |
| 2023-03-29 | $2.68 | $2.78 | $2.67 | $2.71 | 3 464 |
| 2023-03-28 | $2.62 | $2.77 | $2.60 | $2.66 | 19 673 |
| 2023-03-27 | $2.60 | $2.64 | $2.60 | $2.63 | 4 656 |
| 2023-03-24 | $2.67 | $2.72 | $2.61 | $2.64 | 5 695 |
| 2023-03-23 | $2.68 | $2.78 | $2.62 | $2.72 | 7 255 |
About AEterna Zentaris Inc.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. T... AEZS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
